Purchase Report

Report Name : Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

* Required Information
Single User: US $ 6995  US $ 5596 Corporate User: US $ 20985  US $ 16788

We are on:

Buy Any Report Avail 20% Discount. Coupon Code: OCT20